Cutler Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-9,400
| Closed | – | – | 5137 |
|
|
2019
Q1 | $0 | Sell |
9,400
-300
| -3% | -$76 | ﹤0.01% | 5136 |
|
|
2018
Q4 | $1K | Sell |
9,700
-61,545
| -86% | -$40.4K | ﹤0.01% | 3820 |
|
|
2018
Q3 | $121K | Hold |
71,245
| – | – | 0.01% | 1096 |
|
|
2018
Q2 | $123K | Buy |
71,245
+1,389
| +2% | +$2.4K | 0.01% | 1021 |
|
|
2018
Q1 | $127K | Sell |
69,856
-23,200
| -25% | -$49K | 0.01% | 1046 |
|
|
2017
Q4 | $207K | Buy |
93,056
+33,500
| +56% | +$83.3K | 0.01% | 939 |
|
|
2017
Q3 | $172K | Sell |
59,556
-44,203
| -43% | -$151K | 0.01% | 1276 |
|
|
2017
Q2 | $461K | Sell |
103,759
-32,412
| -24% | -$134K | 0.02% | 738 |
|
|
2017
Q1 | $634K | Buy |
136,171
+99,796
| +274% | +$579K | 0.03% | 550 |
|
|
2016
Q4 | $221K | Sell |
36,375
-2,000
| -5% | -$10.5K | 0.01% | 1231 |
|
|
2016
Q3 | $211K | Buy |
38,375
+15,800
| +70% | +$74K | 0.01% | 1165 |
|
|
2016
Q2 | $85K | Sell |
22,575
-2,200
| -9% | -$7.46K | ﹤0.01% | 1843 |
|
|
2016
Q1 | $68K | Sell |
24,775
-10,100
| -29% | -$36.6K | ﹤0.01% | 2005 |
|
|
2015
Q4 | $197K | Buy |
+34,875
| New | +$213K | 0.01% | 1197 |
|
Cutler Group's SGYP Position: Q2 2019 in Review
Cutler Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 9,400 shares.
Cutler Group first reported a position in SGYP in Q4 2015 and held it in 14 quarters. The position peaked at $634K in Q1 2017. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.
- Cutler Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
- Cutler Group sold 9,400 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
- Cutler Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 14 quarters.
- Cutler Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $634K in Q1 2017.
- 2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.
Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.